MolNFT v1 · #125411 · protein
Engineered ascorbate peroxidise
5L86 · Ascorbate peroxidase: “Engineered ascorbate peroxidise”. X-ray diffraction, 2 ligands (HEM, SO4), 2 pockets (best druggability 0.79). MolNFT v1 #125411 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5L86
- Type
- protein
- Length
- 494 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Ascorbate peroxidase
- EC
- 1.11.1.11
- UniProt
- Q43758
- Ligands
- HEM, SO4
- Pockets
- 2 · best druggability 0.79
Structure
x-ray diffraction · 1 distinct chain · 55% helix, 2% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | Ascorbate peroxidase (EC 1.11.1.11) | protein | 247 | 55% helix, 2% strand | Q43758 |
Ligands and binding sites
- HEM · Protoporphyrin IX containing Fe · ligand · 2 copies · chains A, B
- SO4 · Sulfate ion · ion · 6 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 408 | 0.79 | 0.88 | 51 | HEM |
| 2 | 441 | 0.79 | 0.87 | 50 | HEM |
Interfaces
1 interface between chains.
- A–B · 854 Ų buried · 10 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 2 modified (methylation).
Compared structures
- 5L86 · engineered ascorbate peroxidise · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q43758
- Elsewhere: RCSB PDB 5L86 · PDBe 5L86 · UniProt Q43758
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.